Last reviewed · How we verify
Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI)
The primary purpose of this research study is to evaluate the safety and possible harms of injecting one's own Schwann cells along with nerve auto-graft after a severe injury to a major nerve has occurred.
Details
| Lead sponsor | W. Dalton Dietrich |
|---|---|
| Phase | PHASE1 |
| Status | RECRUITING |
| Enrolment | 30 |
| Start date | Thu May 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Sep 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Peripheral Nerve Injury
Interventions
- Autologous Human Schwann Cell
Countries
United States